Resources
We offer many resources to other urban Indian-serving organizations, decisionmakers, legislative partners, the community, and more.
Best Practices in HIV Reporting and Data Collection in American Indian and Alaska Native Communities
Learn more about the stands of reporting HIV in Native communities
Data Genocide of American Indians and Alaska Natives COVID-19 Digital Toolkit
Use this toolkit to help coordinate efforts that will hold state leaders accountable for collecting and reporting COVID-19 data on American Indians and Alaska Natives.
Best Practices for American Indian and Alaska Native Data Collection
Learn best practices for collecting data on American Indian and Alaska Native populations.
Decolonizing Data: Strengthening Community Voices to Take Action for Our Missing Relatives
A webinar in partnership with the National Missing and Unidentified Persons System (NamUs) where you can learn how to enter your missing Native loved ones’ information into the NamUs database.
Decolonizing Identity: Addressing Two-Spirit Health and Well-Being Through Data Collection
The Urban Indian Health Institute has been invited to Trans Pride Seattle 2017! In honor of this invitation UIHI is proud to announce their newest resource: “Decolonizing Identity: Addressing Two-Spirit Health and Well-Being Through Data Collection.” …
Nirsevimab: An RSV Antibody for Infants
A new RSV antibody treatment, Nirsevimab, is available for newborns and infants ages 0 to 19 months. Nirsevimab helps infants build antibodies that protect against severe RSV. Download our factsheet to learn more.
RSV Vaccines and Older Adults
New RSV vaccines, ABRYSVO and AREXVY, are available for older adults. These new vaccines help protect adults ages 60 years and older from developing severe RSV. Download our factsheet to learn more.
RSV Vaccine and Pregnant People
A new RSV vaccine, ABRYSVO, is available for pregnant people and babies. ABRYSVO helps protect pregnant people during 32 to 36 weeks of pregnancy and infants ages 0 to 6 months from severe RSV. Download our …
Information about the AREXVY RSV Vaccine
The AREXVY RSV vaccine helps protect older adults from severe illnesses caused by RSV. AREXVY is for adults 60 years and older, people with underlying health conditions, people with weakened immune systems, and people at high …
Information about the ABRYSVO RSV Vaccine
The ABRYSVO RSV vaccine is for pregnant people at 32 through 36 weeks (about 8and 8 ½ months), people ages 60 years and older, and adults who are at a higher risk for severe illness from …
Information about the COVID-19 Bebtelovimab Monoclonal Antibody Treatment
On February 11, 2022, the US Food and Drug Administration approved the COVID-19 monoclonal antibody (mAb) treatment called bebtelovimab made by Eli Lilly and Co., making it available for emergency use. This fact sheet contains information …
COVID-19 Treatment Map
It’s as important as ever to know where you can get treatment to mitigate the worst outcomes of COVID-19 if infected. It is also equally important for high-risk individuals to know where to receive pre-exposure prophylaxis. …
“Heroes Carry Narcan” Poster
On this International Overdose Awareness Day, and all the days that come after, know that YOU can be a hero by carrying Narcan—a nasal spray with the power to reverse an opioid overdose. Carrying and knowing …
Clinical Trial Participation Guide for American Indians and Alaska Natives: Partner Toolkit
This toolkit is intended to help healthcare providers share culturally attuned information about clinical trials with their American Indian and Alaska Native patients.
Information about the COVID-19 Bamlanivimab and Etesevimab Monoclonal Antibodies Treatment
On February 9, 2021, the US Food and Drug Administration approved the COVID-19 monoclonal antibodies (mAbs) treatment, bamlanivimab (bam-la-niv-i-mab) and etesevimab (e-te-sev-i-mab), that is administered together as a single treatment to prevent severe illness in those …
Information about the COVID-19 REGEN-COV Monoclonal Antibody Treatment
On November 21, 2020, the US Food and Drug Administration authorized a COVID-19 cocktail monoclonal antibody (mAb) treatment called REGEN-COV made by Regeneron Pharmaceutical, Inc. for emergency use during the current pandemic. As of January 24, …
Urban Diabetes Care and Outcomes Audit Summary Brief, 2020
Learn more about the 2020 Urban Diabetes Audit
Building the Sacred: An Indigenous Evaluation Framework for Programs Serving Native Survivors of Violence
Building the Sacred: An Indigenous Evaluation Framework for Programs Serving Native Survivors of Violence illustrates four places from which Indigenous evaluation is already taking place in violence prevention, response, and healing programs.
Service as Ceremony: A Journey toward Healing
This is the story of 24 direct-service providers who work in gender-based violence programs in urban and rural tribal communities across the United States.
Addressing Racial Misclassification
Learn ways to ensure American Indian and Alaska Native communities are included in data
Responding to Emerging HIV Clusters
Learn recommendations for providers to limit the emergence of HIV clusters
